Answers are grounded in this paper and cite their sources.
Sir, The production of carbapenem-hydrolysing β-lactamases of the KPC-type is an increasingly important mechanism of resistance to carbapenems in Gram-negative bacteria. Since the report of the first isolate in 2001, in a clinical specimen of Klebsiella pneumoniae from a hospital in North Carolina,1 the geographic range of KPC-type enzymes has expanded worldwide. The blaKPC genes are usually found on mobile genetic elements that are horizontally transferred and give them an extraordinary spreading capacity. They have been detected more often in Klebsiella spp.,2 but have also been reported in other Enterobacteriaceae3 and in Pseudomonas.4 Herein we report the detection of three clonally related KPC carbapenemase-producing clinical isolates of Citrobacter freundii in our hospital during late 2009 and early 2010. The first was from a young male patient who underwent an allogeneic bone marrow transplant in the context of a recurrent acute myeloid leukaemia. The transplant was complicated with graft-versus-host disease and a prolonged admission. He was subjected to several photopheresis sessions through a femoral intravenous catheter and 2 months later he developed a fulminant septic shock complicated with acute respiratory distress syndrome, consistent with a catheter-related infection. Enterococcus faecalis and C. freundii were isolated from blood cultures. At that time he was receiving vancomycin, meropenem, liposomal amphotericin B and prophylactic aciclovir. Colistin was added empirically, but he died 36 h later. During his admission the patient had developed several episodes of febrile neutropenia and had received large amounts of antibiotics. Two more cases were detected 3 months later (January 2010). One of the isolates was obtained from a urine sample from an elderly diabetic outpatient with end-stage renal disease on peritoneal dialysis. He had been admitted several times during the previous few months, but he did not share a ward with the other patients infected with the KPC-2-producing strain or receive medical treatment from the teams who treated them. The third isolate was obtained from an elderly patient who had twice undergone surgery for severe biliary pancreatitis, and who developed an abdominal abscess, multi-organ failure and nosocomial pneumonia. The patient died 10 days after an episode of sepsis. The KPC-producing isolate was obtained from a sample of a retroperitoneal abscess that yielded a mixed aerobic and anaerobic flora. The isolates exhibited identical antibiograms, with resistance to carbapenems, penicillins, cephalosporins, cefoxitin, aztreonam, ciprofloxacin, gentamicin, tobramycin and trimethoprim/sulfamethoxazole, but susceptibility to amikacin, colistin and tigecycline. MICs of imipenem, meropenem, doripenem and ertapenem were >32 mg/L (Etest). Strong carbapenemase activity was confirmed by the modified Hodge test,5 but the Etest with imipenem/imipenem-EDTA strips did not show inhibition, indicating that the activity was not due to a class B metalloenzyme. PCR analysis with specific oligonucleotides (KPC-F, 5′-ATGTCACTGTATCGCCGTCT-3′; and KPC-R, 5′-TTTTCAGAGCCTTACTGCCC-3′) showed the presence of blaKPC genes in each isolate. Sequencing of the PCR product identified the enzyme as KPC-2. Additional PCR analyses did not detect genes for extended-spectrum β-lactamase families (TEM, SHV, OXA and CTX-M). Random amplification of polymorphic DNA (RAPD) with three different oligonucleotides6 yielded band patterns that were identical for the three isolates and different from a set of five unrelated strains obtained during the same period, indicating that the three KPC-2-producing isolates were clonally related, although no epidemiological relation was found between the three patients. None of them had recently travelled abroad and they had not been transferred from a foreign centre. Although further infections caused by bacteria producing this carbapenemase were anticipated, no further cases have been observed. Surveillance rectal swabs were obtained from all the patients admitted in the haemo-oncology ward after the first case and twice monthly since then, but no other KPC-producing isolates were found. Active surveillance cultures and reinforcement of infection control practices probably contributed to the avoidance of further infections. Several reports of carbapenem-resistant Enterobacteriaceae in Spain6–8 have been published, but the isolates reported produced class B metalloenzymes in most cases. Recently, Curiao et al.9 detected the first blaKPC-3 genes described in Spain associated with endemic multiresistant clones of K. pneumoniae. The finding of three KPC-producing isolates in different patients without apparent epidemiological links suggests an unexpectedly wide distribution of either the C. freundii strain or the blaKPC-carrying genetic element. The fact that two different blaKPC genes have been isolated in a short period of time in two geographically close hospitals (they serve contiguous areas in Madrid and are less than 1 km apart) suggests that these are not sporadic cases, but are spreading into Spain. Microbiological surveillance, supported by Hodge test analysis in Enterobacteriaceae showing MICs of carbapenems >1 mg/L, and molecular confirmatory assays would be advisable for monitoring and prevention of epidemic spreading. The data presented were obtained as part of the routine work of the Microbiology Department of Hospital Universitario La Paz. J. M. was supported by a Ramón y Cajal fellowship (Spanish Ministerio de Ciencia e Innovación and European Social Fund). None to declare.
No takes yet. Share an insight, caveat, or question.
Gómez-Gil et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: